Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
whereas the flavone showed no cytotoxicity against human peripheral blood mononuclear cells (PBMCs)
MLN-9708 treatment increases the levels of pro-apoptotic proteins and down regulates the anti-apoptotic proteins that control MOMP
CAS Number: 83280-65-3
941678-49-5
is a drug used for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure
TAK-715 odiamide hydrate whereas the flavone showed noTAK 715 is a potent p38 MAPK inhibitor. which displays potent inhibitory activity (inhibition of p38alpha, IC50 = 7. 1 nM; LPS stimulated release of TNF alpha from THP 1, IC50 = 48 nM; LPS induced TNF alpha production in mice, 87. 6% inhibition at 10 mg kg, po) and no inhibitory activity for major CYPs, including CYP3A4. TAK 715 was selected as a clinical candidate and is now under clinical investigation for the treatment of RA. Product information